Pfizer Independent Medical
Education RFP
Increase Awareness &Understanding of Emerging
Hemophilia Treatment Options
Competitive Grant Program –Pfizer Internal Review ProcessOverview
This competitive program seeks to encourage organizations tosubmit grant applications for independent medical education
initiatives that will result in the measurable improvement of the
medical and scientific understanding of emerging treatment
options for patients with Hemophilia.

Geographic Scope
Global (excluding United States)

Project Types and Area of Interest
Potential applicants are encouraged to identify and address
the educational needs of healthcare professionals to increaseawareness of emerging hemophilia treatment options.

Key Milestones• Applications will be accepted on a rolling basis throughOctober but reviewed based on the timelines listed in theKey Dates section.

Funding Range•

Individual projects requesting up to $100,000 will beconsidered.

I. Eligibility
Geographic Scope:•Global (excluding United States)

Applicant Eligibility Criteria
••

•

•

Only organizations are eligible to receive grants, not individuals or medical practice groups.
The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools;
healthcare institutions (both large and small); professional associations and medical societies; patientadvocacy groups; medical education companies; and other entities with a mission related to healthcare
professional education and/or healthcare improvement.
If the project involves multiple departments within an institution and/or between different institutions /organizations / associations. All institutions must have a relevant role and the requesting organizationmust have a key role in the project.
For projects offering continuing education credit, the requesting organization must be accredited.

II. Requirements
Date RFP Issued•

26 June 2024

Clinical Area•

Hemophilia

General Area of Interest for this RFP:
Projects that will be considered for Pfizer support will focus on:• Educating on the evolving treatment landscape (i.e. genetic medicine, rebalancing strategies) for
hemophilia to improve the understanding of these novel approaches and their potential clinicalapplicability.
• Discussing shared decision making (SDM) and practical approaches on how SDM can beincorporated into hemophilia patient care1• Educating on the benefits of omnichannel healthcare strategies which can provide a seamless,personalized service and patient care experience2• Sharing knowledge and best practices (i.e. staff training, SOP, follow-up care) on how
Hemophilia Treatment Centers (HTCs) and multidisciplinary team are preparing for novel
therapies in development• Advancing patient education on the evolving hemophilia treatment landscape and improving
patient’s empowerment and ability to make informed decisions about their care

Target Audience•

Members of multidisciplinary teams that care for Hemophilia patients including but not limited toHematologists, Pharmacists, Specialty Nurses, Genetic Counsellors, Medical Geneticists, and otherPhysicians

2Expected Approximate Monetary Range of Grant Applications:••Individual projects requesting up to $100,000 will be considered.
This RFP will remain open while funds last. Once the full budget is spent the RFP will be closed and new
requests will no longer be accepted.

Key Dates:••

RFP release date: 26 June 2024
Applications will be accepted on a rolling basis through September but reviewed based on the timelines
below:
Application
Submitted by•Decision Notification
Date

Program Start Datemust be after

31 July 2024

4 September 2024

15 September 2024

30 September 2024

4 November 2024

15 November 2024

Grants will be distributed following a fully executed agreement.

How to Submit:•

Note: Please read this section carefully since applications submitted not following these instructions will
not be accepted and will be cancelled
Please go to www.cybergrants.com/pfizer/knowledge and sign in. First-time users should click“Create your password”. [Note: there are individual portals for each grant application type. Please be sure to usethe URL above.]••••

Click the “Start A New Knowledge Gap Application" button.
In the application:• For the question “What type of request are you submitting?” select Response to a Request forProposal (RFP)• For the question “Are you replying to a Request for Proposal (RFP) as part of the Competitive
Grant Program?” select Yes• Select the following Competitive Grant Program Name: 2024 RD Global Hemophilia Education
Requirements for submission:• Complete all required sections of the online application and upload your project proposal (seeAppendix) in the General RFP Submission field.
If you encounter any technical difficulties with the website, please click the “Technical Questions” link atthe bottom of the page.
IMPORTANT: Be advised applications submitted after the due date will not be reviewed.

Questions:•If you have questions regarding this RFP, please direct them in writing to the Grant Officer, Amanda
Stein (amanda.j.stein@pfizer.com@pfizer.com), with the subject line “Hemophilia Education.”

3

Grant Agreements:•••

If your grant is approved, your institution will be required to enter into a written grant agreement with
Pfizer. Please click here to view the core terms of the agreement.
Pfizer has drafted the terms of these agreements to be balanced and reasonable and to further the goalsof both parties. Negotiating grant agreements requires significant resources, so please ensure that yourinstitution (including your legal department) is able and willing to abide by these terms before proceedingwith submission of your application as they will need to be accepted in their entirety.
Payment will only be made to requesting Institution.

Review and Approval Process•Grant requests received in response to a general RFP are reviewed by Pfizer to make final grantdecisions.

Mechanism by which Applicants will be Notified:••

All applicants will be notified via email by the dates noted above.
Applicants may be asked for additional clarification during the review period.

References:
1. Valentino,L.,Blanchette,V.,Negrier,C.,O’Mahony,B.,Bias,V.,Sannié,T. &Skinner,M.(2021).Personalising haemophilia management with shared decision making. The
Journal of Haemophilia Practice,8(1) 69-79. https://doi.org/10.17225/jhp00178
2. Moreira A, Alves C, Machado J, Santos MF. An Overview of Omnichannel Interaction in HealthCare Services. Mayo Clin Proc Digit Health. 2023 Jun;1(2):77-93. doi:
10.1016/j.mcpdig.2023.03.002. Epub 2023 Apr 3. PMID: 38013946; PMCID: PMC10069288.

About Pfizer Global Medical Grants
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives(e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical
need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP)
that provides detail regarding a general area of interest, sets timelines for review and approval, and uses
an internal Pfizer review process to make final grant decisions. Organizations are invited to submit anapplication addressing the knowledge gaps as outlined in the specific RFP.
For all independent medical education grants, the grant requester (and ultimately the grantee) isresponsible for the design, implementation, and conduct of the independent initiative supported by thegrant. Pfizer must not be involved in any aspect of project development, nor the conduct of the
independent education program.

4

Appendix
General RFP Submission Requirements
Applications will be accepted via the online portal listed in the How to Submit section. Project
Proposals should be single-spaced using Calibri 12-point font and 1-inch margins. Note there is a
10-page limit exclusive of references. When uploading your Project Proposal please ensure it
addresses the following sections:Goals and Objectives••

Briefly state the overall goal of the project.
List the objectives you plan to meet with your project, in terms of learning and expected outcomes.

Needs Assessment for the Project•

Include a description of your organization’s needs assessment for this proposed project which may
include a quantitative baseline data summary, initial metrics, or a project starting point (please cite dataon gap analyses or relevant patient-level data that informs the stated objectives) in your target area.

Target Audience•Describe the primary audience(s) targeted for this project. Indicate whom you believe will directly benefit
from the project outcomes. Describe the overall population size as well as the size of your sample
population.

Project Design and Methods••

Describe the planned project, the educational approach, and the way the planned methods address theestablished need.
Please describe how your proposal and/or your team seek to promote diversity, equity, and inclusion inthis project.

Innovation•Explain what measures you have taken to assure that this project is original and does not duplicate
other projects or materials already developed. Describe how this project builds upon existing work, pilot
projects, or ongoing projects developed either by your institution or other institutions.

Evaluation and Outcomes•In terms of the metrics used for the needs assessment, describe how your organization will determine if
the gap was addressed for the target group. Identify the sources of data your organization anticipatesusing to make the determination. Describe how your organization is expected to collect and analyze thedata. Explain the method used to control for other factors outside this project (e.g., use of a control groupor comparison with baseline data). Quantify the amount of change expected from this project in terms thetarget audience. Describe how your organization will determine if the target audience was fully engaged
in the project.

Dissemination Plan•

Describe how the project may have extended benefit beyond the grant. Will the teaching materials be
made available to others to use? Will there be tools or resources that are made publicly available
beyond the initial project. Describe how the project outcomes might be broadly disseminated.

5

Anticipated Project Timeline•Provide an anticipated timeline for your project including project start/end dates.

Additional Information•

If there is any additional information you feel Pfizer should be aware of concerning the importance of thisproject, please summarize here

Organization Detail•

Describe the attributes of the institutions / organizations / associations that will support and facilitate theexecution of the project and the leadership of the proposed project. Articulate the specific role of eachpartner in the proposed project.

Budget Detail••

Please include a budget narrative that describes in greater detail the line items specified in the budget
submitted within the application
While estimating your budget please keep the following items in mind:• Independent Medical Education Grants awarded by GMG cannot be used to purchase therapeuticassets (prescription or non-prescription).
• Overhead rates of up to 28% of the total proposed project budget may be supported by Pfizer.
Please click here for details.

6